BIRAC-Call For Proposal

BIRAC Announces 37th BIPP Speical Call for Proposals under Biopharmaceuticals (15th Feb,2016 - 31st Mar, 2016)

Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Undertaking, of Department of Biotechnology, Ministry of Science & Technology, Government of India, has been set up to nurture the Biotech Innovation Ecosystem, support Start-ups and SME’s for innovation research and promote affordable product development through public-private partnership

Click here to view Detailed Document

Click here to register for BIPP/SBIRI

An Advanced Technology Scheme for high risk,transformational technology/ process development from proof-of-concept to validation leading to high value product commercialization 

• Support new and futuristic technology development with major social bearing but uncertain market driven demand

• Support start-ups, SME’s and other Biotech companies on cost sharing basis

A single or consortia of Indian company (ies) registered under “The Indian Companies Act 2013” with minimum 51%

Indian ownership, and DSIR recognized in-house R&D unit, are eligible to apply either alone, or in collaboration with

a partner from another Company/Institute/University

(Companies in the process of obtaining DSIR recognition may also apply; however, their funding would be subject to

getting DSIR recognition)

Proposals for the Scheme is required to be submitted online only. To submit a proposal online, please log on to the BIRAC website (www.birac.nic.in).

 No Hard Copy to be submitted. Proposals submitted online only would be considered.

Last date for Submission of Proposals : 31st Mar 2016

Details of the scheme including eligibility requirements, categories for proposal submission; guidelines for support as grant  agreement templates etc. are available at www.birac.nic.in

For any queries, please contact

Head Investment, BIRAC. Email: investment.birac@gov.in

Announcement Date: 15-02-2016
Last Submission Date: 31-03-2016 12:00 AM

Copyright © 2024 BIRAC. All Rights Reserved.